Patents/Inventors

Thomas Duhen

Portland, ORUS1 patent

2 Patents

US123589682025
Utilization of CD39 and CD103 for Identification of Human Tumor Reactive T Cells for Treatment of Cancer
Agonox, Inc.
0 cites
US115725412023
Utilization of CD39 and CD103 for Identification of Human Tumor Reactive T Cells for Treatment of Cancer
Agonox, Inc.
0 cites